Unicycive Therapeutics, Inc. (UNCY) — DEFA14A Filings
All DEFA14A filings from Unicycive Therapeutics, Inc.. Browse 4 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (4)
-
Unicycive Therapeutics Files Definitive Proxy Materials
— Apr 30, 2026 Risk: low
Unicycive Therapeutics, Inc. filed a DEFA14A form on April 30, 2026, which contains additional definitive proxy soliciting materials. The filing includes docume -
Unicycive Therapeutics Files Proxy Statement Supplement
— May 22, 2025 Risk: low
Unicycive Therapeutics, Inc. filed a Definitive Additional Materials filing (DEFA14A) on May 22, 2025, supplementing its proxy statement for the Annual Meeting -
Unicycive Therapeutics Files Proxy Statement Supplement
— May 7, 2025 Risk: low
Unicycive Therapeutics, Inc. filed an amendment and supplement to its proxy statement for the upcoming Annual Meeting. This filing, dated May 7, 2025, is a defi -
Unicycive Therapeutics Files Definitive Additional Materials
— May 8, 2024 Risk: low
Unicycive Therapeutics, Inc. filed a Definitive Additional Materials (DEFA14A) on May 8, 2024, supplementing its proxy statement for the Annual Meeting of Stock
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX